Skip to main content

Man Group plc

SEC CIK
0001637460
Latest filing
Aug 14, 2026

CORT holding history

Corcept Therapeutics Inc in every 13F filed by Man Group plc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CORT overviewAll 13F holders of CORTFull Q2 2026 holdings

Shares (Q2 2026)
71,491
Value
$6.22M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of CORT by Man Group plc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202671,491$6.22M<0.1%−6,113−7.9%ReducedHolders
Q1 202677,604$3.13M<0.1%−13,104−14.4%ReducedHolders
Q4 202590,708$3.16M<0.1%−81,889−47.4%ReducedHolders
Q3 2025172,597$14.3M<0.1%−237,542−57.9%ReducedHolders
Q2 2025410,139$30.1M0.1%−219,036−34.8%ReducedHolders
Q1 2025629,175$71.9M0.2%+341,295+118.6%AddedHolders
Q4 2024287,880$14.5M<0.1%−62,653−17.9%ReducedHolders
Q3 2024350,533$16.2M<0.1%−479,410−57.8%ReducedHolders
Q2 2024829,943$27.0M0.1%−668,977−44.6%ReducedHolders
Q1 20241,498,920$37.8M0.1%+672,819+81.4%AddedHolders
Q4 2023826,101$26.8M0.1%––Holders
Q3 2023–$16.5M0.1%––Holders
Q2 2023615,925$13.7M<0.1%––Holders
Q1 2023–$14.3M0.1%––Holders
Q4 2022685,386$13.9M<0.1%−63,015−8.4%ReducedHolders
Q3 2022748,401$19.2M0.1%––Holders
Q2 2022–$26.3M0.1%––Holders
Q1 2022445,740$10.0M<0.1%−4,674−1.0%ReducedHolders
Q4 2021450,414$8.92M<0.1%+42,549+10.4%AddedHolders
Q3 2021407,865$8.03M<0.1%+34,818+9.3%AddedHolders
Q2 2021373,047$8.21M<0.1%+84,292+29.2%AddedHolders
Q1 2021288,755$6.87M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.